Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCEPTION study of allergic factors after JOYCLU (SI-613/ONO-5704) injection
jRCT1040220009Completed
- Sponsor
- Nishida Pharmaceutical
- Start
- Apr 2022
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of diclofenac etalhyaluronate in knee osteoarthritis (OA) and hip osteoarthritis (2 cohorts), sponsored by Nishida Pharmaceutical. Primary endpoints: Basophil Activation Test, Allergen-specific IgE test (ELISA) and 2 more. Started Apr 2022; status: completed.
02
Drugs
diclofenac etalhyaluronate
03
Conditions
knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on jRCT1040220009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1040220009.